[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HRP970630B1 - Hepapeptide oxytocin analogues - Google Patents

Hepapeptide oxytocin analogues

Info

Publication number
HRP970630B1
HRP970630B1 HR970630A HRP970630A HRP970630B1 HR P970630 B1 HRP970630 B1 HR P970630B1 HR 970630 A HR970630 A HR 970630A HR P970630 A HRP970630 A HR P970630A HR P970630 B1 HRP970630 B1 HR P970630B1
Authority
HR
Croatia
Prior art keywords
hepapeptide
oxytocin analogues
oxytocin
analogues
hepapeptide oxytocin
Prior art date
Application number
HR970630A
Other languages
English (en)
Inventor
Per Melin
Anders Nilsson
Jerzy A Trojnar
Carl-Johan Aurell
Pierre Riviere
Robert Haigh
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of HRP970630A2 publication Critical patent/HRP970630A2/hr
Publication of HRP970630B1 publication Critical patent/HRP970630B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HR970630A 1996-11-26 1997-11-21 Hepapeptide oxytocin analogues HRP970630B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9604341A SE9604341D0 (sv) 1996-11-26 1996-11-26 Hepta-peptide oxytocin analogue

Publications (2)

Publication Number Publication Date
HRP970630A2 HRP970630A2 (en) 1998-10-31
HRP970630B1 true HRP970630B1 (en) 2002-04-30

Family

ID=20404757

Family Applications (1)

Application Number Title Priority Date Filing Date
HR970630A HRP970630B1 (en) 1996-11-26 1997-11-21 Hepapeptide oxytocin analogues

Country Status (35)

Country Link
US (1) US6143722A (pl)
EP (1) EP0938496B1 (pl)
JP (1) JP3405460B2 (pl)
KR (1) KR100463132B1 (pl)
CN (1) CN1129606C (pl)
AR (1) AR008531A1 (pl)
AT (1) ATE242264T1 (pl)
AU (1) AU713424B2 (pl)
BR (1) BR9713366B1 (pl)
CA (1) CA2272990C (pl)
CZ (1) CZ299532B6 (pl)
DE (1) DE69722651T2 (pl)
DK (1) DK0938496T3 (pl)
EE (1) EE03832B1 (pl)
ES (1) ES2203823T3 (pl)
HK (1) HK1022481A1 (pl)
HR (1) HRP970630B1 (pl)
HU (1) HU228568B1 (pl)
IL (1) IL129519A (pl)
LT (1) LT4650B (pl)
LV (1) LV12350B (pl)
MY (1) MY125555A (pl)
NO (1) NO321380B1 (pl)
NZ (1) NZ336445A (pl)
PL (1) PL189292B1 (pl)
PT (1) PT938496E (pl)
RO (1) RO120772B1 (pl)
RU (1) RU2180668C2 (pl)
SE (1) SE9604341D0 (pl)
SI (1) SI20026B (pl)
SK (1) SK283800B6 (pl)
TR (1) TR199901028T2 (pl)
UA (1) UA54459C2 (pl)
WO (1) WO1998023636A1 (pl)
ZA (1) ZA9710518B (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
US6476072B1 (en) * 2000-11-21 2002-11-05 Arthur Vanmoor Method of treating menstrual pain by enhancing the effectiveness of the human immune system
AU2003211011A1 (en) * 2002-02-27 2003-09-09 Ferring Bv Intermediates and methods for making heptapeptide oxytocin analogues
WO2003093816A2 (en) * 2002-05-02 2003-11-13 Bayer Healtchare Ag Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
UA76639C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
ES2260563T3 (es) * 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
EP1555029A1 (en) 2004-01-19 2005-07-20 Ferring B.V. Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension
US20060171909A1 (en) * 2005-02-03 2006-08-03 The Procter & Gamble Company Cosmetic compositions comprising colorants with low free dye
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
AU2008283929B2 (en) 2007-08-06 2013-10-10 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
DK2260053T3 (da) * 2008-03-31 2014-06-23 Ferring Bv Oxytocin-analoger
PT3225250T (pt) 2008-05-21 2019-10-15 Ferring Bv Desmopressina orodispersivel para aumentar o periodo inicial de sono não perturbado pela nocturia
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
TWI463990B (zh) * 2009-09-21 2014-12-11 Ferring Bv 催產素受體促進劑
MX2013000543A (es) 2010-07-15 2013-10-28 Oleg Iliich Epshtein Un metodo para aumentar el efecto de una forma activa potenciada de un anticuerpo.
JO3400B1 (ar) * 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
JP6150726B2 (ja) 2011-03-09 2017-06-21 Jitsubo株式会社 新規な非ペプチド性架橋構造を含む架橋ペプチド、ならびに該架橋ペプチドの合成方法および該方法に用いる新規な有機化合物
CN102875650B (zh) * 2012-09-26 2014-06-11 深圳翰宇药业股份有限公司 巴卢西班的制备方法
US9365615B2 (en) 2013-09-09 2016-06-14 Jitsubo Co., Ltd. Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
PL3037101T3 (pl) * 2014-12-22 2019-06-28 Ferring B.V. Terapia antagonistą receptora oksytocyny w fazie lutealnej w celu implantacji i uzyskania ciąży u kobiet poddawanych technikom wspomaganego rozrodu
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US20180282367A1 (en) 2015-10-06 2018-10-04 Ferring B.V. New methods for making barusiban and its intermediates
EA036990B1 (ru) 2016-01-04 2021-01-25 Мерк Сероно С.А. (3s)-3-({[(2s)-3-(бифенил-4-илсульфонил)-1,3-тиазолидин-2-ил]карбонил}амино)-3-(4-фторфенил)пропил l-валинат и его солевая форма, кристаллический полиморф
MA52548A (fr) 2016-07-21 2021-05-26 ObsEva SA Régimes posologiques d'antagonistes de l'ocytocine pour favoriser l'implantation d'embryons et prévenir les fausses couches
CN114667141A (zh) 2019-09-03 2022-06-24 奥布赛瓦股份公司 用于促进胚胎移植和预防流产的催产素拮抗剂给药方案
AU2021218895A1 (en) 2020-02-10 2022-09-15 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2036973A1 (en) * 1990-02-27 1991-08-28 Mark G. Bock Cyclic hexapeptide oxytocin antagonists
SE9002384D0 (sv) * 1990-07-09 1990-07-09 Ferring Ab Derivat av baklobshormoner
SE501678C2 (sv) * 1993-07-13 1995-04-10 Ferring Bv Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
SE523819C2 (sv) 1994-01-27 2004-05-18 Per-Ingvar Nilsson Accelerationsmunstycke samt metod för dess användning
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
SE9500249L (sv) 1995-01-25 1996-03-25 Valeo Engine Cooling Ab Värmeväxlartank med ändstycken, förfarande för framställning av en sådan tank, samt värmeväxlare försedd med en sådan

Also Published As

Publication number Publication date
IL129519A (en) 2004-09-27
CN1129606C (zh) 2003-12-03
KR20000069045A (ko) 2000-11-25
BR9713366B1 (pt) 2010-05-18
MY125555A (en) 2006-08-30
CZ299532B6 (cs) 2008-08-27
ATE242264T1 (de) 2003-06-15
NZ336445A (en) 2000-06-23
KR100463132B1 (ko) 2004-12-23
HUP0000577A3 (en) 2001-02-28
EP0938496B1 (en) 2003-06-04
RO120772B1 (ro) 2006-07-28
ZA9710518B (en) 1998-06-10
JP2000507617A (ja) 2000-06-20
HK1022481A1 (en) 2000-08-11
CA2272990A1 (en) 1998-06-04
US6143722A (en) 2000-11-07
LT4650B (lt) 2000-04-25
NO321380B1 (no) 2006-05-02
LT99052A (en) 2000-01-25
EE03832B1 (et) 2002-08-15
PT938496E (pt) 2003-10-31
NO992532D0 (no) 1999-05-26
HRP970630A2 (en) 1998-10-31
HUP0000577A2 (hu) 2000-11-28
ES2203823T3 (es) 2004-04-16
SE9604341D0 (sv) 1996-11-26
RU2180668C2 (ru) 2002-03-20
SK283800B6 (sk) 2004-02-03
NO992532L (no) 1999-05-26
IL129519A0 (en) 2000-02-29
CN1238781A (zh) 1999-12-15
PL189292B1 (pl) 2005-07-29
DK0938496T3 (da) 2003-10-06
HU228568B1 (en) 2013-04-29
AR008531A1 (es) 2000-01-19
DE69722651T2 (de) 2004-04-08
EE9900210A (et) 1999-12-15
SI20026B (sl) 2000-06-30
CZ183299A3 (cs) 2000-05-17
EP0938496A1 (en) 1999-09-01
TR199901028T2 (xx) 1999-07-21
LV12350B (en) 1999-11-20
DE69722651D1 (en) 2003-07-10
JP3405460B2 (ja) 2003-05-12
BR9713366A (pt) 2000-01-25
AU5142998A (en) 1998-06-22
LV12350A (lv) 1999-09-20
SI20026A (sl) 2000-02-29
UA54459C2 (uk) 2003-03-17
WO1998023636A1 (en) 1998-06-04
SK70499A3 (en) 2000-10-09
AU713424B2 (en) 1999-12-02
CA2272990C (en) 2002-11-19

Similar Documents

Publication Publication Date Title
HRP970630B1 (en) Hepapeptide oxytocin analogues
DE59704951D1 (en) Plättchenförmiges titandioxidpigment
DE59705192D1 (en) Lcp-blends
HK1027968A1 (en) Aerosols
DE59700372D1 (en) Blockcopolymere
HU9700926D0 (en) Vitamine d3 analogues
EP0996458A4 (en) SANDRAMYCIN ANALOG
HK1027731A1 (en) Vacuum-cleaner
GB2333405B (en) Grommet
DE59703905D1 (en) Linearmotorgetriebene transportanlage
SG70116A1 (en) Air extraction
IL117498A0 (en) Tefillin case
DE59702027D1 (en) Bragg-modulator
DE59703023D1 (en) Cyclopeptidderivate
AU133728S (en) Canister
GB9608180D0 (en) Phosphate analogues
PL326379A1 (en) Aspirator
HUP9901287A3 (en) Coin-checking arrangement
GB9713478D0 (en) Bug guard
AU131198S (en) Handleset
AU131199S (en) Handleset
CA79582S (en) Jerkin
HU1174U (en) Case
PL332963A1 (en) Nalpha-2-(4-nitrophenylsulphonyl) ethoxycarboxylaminoacids
GB9608009D0 (en) By-product

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20160928

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20171121